Physician
Kokturk, Tolga
Kokturk, Tolga was paid $216K by Medicaid between Jul 2018 and Nov 2024, across 19 billing codes. Its largest line is 87624, Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types — 24% of everything it billed.
33Billing provider infoKOKTURK, TOLGA
PAWTUCKET, RI 02860
PAWTUCKET, RI 02860
33aNPI1083645592assigned 07/05/2006
33bProvider typeObstetrics & Gynecology Physician
28Total paid$216K
24GClaims2,839
24DCodes billed19
24AFirst – last monthJul 2018 – Nov 2024
Compared with peers
Next to other Obstetrics & Gynecology Physician providers in Rhode Island
Rank by total paid#19 of 106
Median peer was paid$8K
This provider vs. median26×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 42 | $3K | |
| 2019 | 12 | $862.40 | |
| 2020 | 224 | $18K | |
| 2021 | 702 | $53K | |
| 2022 | 557 | $42K | |
| 2023 | 607 | $45K | |
| 2024incomplete | 695 | $55K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 24% | 457 | 448 | $51K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 22% | 662 | 650 | $47K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 10% | 157 | 155 | $23K |
| 76801 | 8.2% | 301 | 279 | $18K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 8.0% | 366 | 351 | $17K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 7.5% | 264 | 260 | $16K |
| 76813 | 7.4% | 223 | 215 | $16K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 7.0% | 145 | 142 | $15K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 2.0% | 64 | 60 | $4K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 1.0% | 25 | 25 | $2K |
| 87340 | <1% | 25 | 25 | $2K | |
| 86780 | <1% | 25 | 25 | $1K |
7 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.